Charles River Laboratories International (CRL) Cash from Investing Activities Growth (3y) (2012 - 2025)
Charles River Laboratories International (CRL) Cash from Investing Activities Growth (3y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -41.81% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 5.49% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 5.31% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -59.07% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 0.00% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 4.07% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -86.97% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -11.88% |
| 10 | Charles River Laboratories International | 11.36 Bn | 11.15 Bn | 744.94 Mn | -59.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | -59.94% |
| Sep 27, 2025 | 28.50% |
| Jun 28, 2025 | 56.77% |
| Mar 29, 2025 | 22.58% |
| Dec 28, 2024 | -116.71% |
| Sep 28, 2024 | 60.84% |
| Jun 29, 2024 | 59.83% |
| Mar 30, 2024 | 14.65% |
| Dec 30, 2023 | -39.18% |
| Sep 30, 2023 | -3.96% |
| Jul 1, 2023 | -38.84% |
| Apr 1, 2023 | 25.86% |
| Dec 31, 2022 | 37.97% |
| Sep 24, 2022 | -14.51% |
| Jun 25, 2022 | 4.37% |
| Mar 26, 2022 | -67.61% |
| Dec 25, 2021 | 28.69% |
| Sep 25, 2021 | -120.74% |
| Jun 26, 2021 | -4.91% |
| Mar 27, 2021 | -77.53% |